Search Results - "Fox CS"

Real-world outcomes of Finerenone in patients with diabetic kidney disease in Saudi Arabia.

Authors: Albekery, Mohamed A. Alhomoud, Ibrahim S. Alamer, Khalid A. et al.

Source: PLoS ONE. 7/1/2026, Vol. 21 Issue 7, p1-12. 12p.

Body composition and cardiovascular disease: Clinical implications beyond body mass index.

Authors: Yetim, Mucahit Kalçık, Macit Birgün, Abdülmelik et al.

Source: Journal of Clinical & Experimental Investigations. Jun2026, Vol. 17 Issue 2, p1-11. 11p.

U-shaped association between waist-to-height ratio and microalbuminuria: A cross-sectional analysis conducted within the Chinese demographic.

Authors: Huang, Xia Hu, Haofei He, Lishu et al.

Source: PLoS ONE. 5/19/2026, Vol. 21 Issue 5, p1-19. 19p.

Within-individual variation of HbA1c measurements in primary care: A retrospective cohort study.

Authors: Gough, Alex Marshall, Tom Sitch, Alice

Source: PLoS ONE. 10/3/2025, Vol. 20 Issue 10, p1-14. 14p.

Is primary aldosteronism a frequent form of hypertension? Data from the Czech Registry and the Czech Institute of Health Information and Statistics.

Authors: Widimsky, Jiri Nikrynova Nguyen, Thi Minh Phuong Ramik, Zdenek et al.

Source: Blood Pressure. Dec2025, Vol. 34 Issue 1, p1-8. 8p.

Modern Management of CKM Syndrome: Use of GLP-1 Receptor Agonists in a Multidisciplinary Setting—Expert Group Recommendations from Kuwait.

Authors: Aldahi, Waleed A. Alenezi, Abdullah Alessa, Thamer et al.

Source: Diabetes Therapy. Mar2026, Vol. 17 Issue 3, p373-389. 17p.

Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category.

Authors: Navas, Angelo Noone, Joshua Laney, Nathan et al.

Source: Diabetes Therapy. Jun2026, Vol. 17 Issue 6, p897-910. 14p.

Vascular dysfunction is associated with major adverse cardiovascular events in prediabetes: A cohort study.

Authors: Kozlova, Dariya Gimblet, Colin Wendt, Linder et al.

Source: PLoS ONE. 6/5/2025, Vol. 20 Issue 6, p1-11. 11p.

Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design.

Authors: Fujiki, Shinya Iijima, Kenichi Okabe, Masaaki et al.

Source: Diabetes Therapy. Nov2020, Vol. 11 Issue 11, p2739-2755. 17p.

Advanced MDCT assessment of abdominal aortic wall integrity and morphometry in the Saudi cohort: A single-centre cross-sectional study.

Authors: Alloush, Mohammad Ahmad Mostafa Hassib, Mazin Babikir Alturkistani, Husain et al.

Source: PLoS ONE. 8/11/2025, Vol. 20 Issue 8, p1-11. 11p.

Advancements and Challenges in the Use of Artificial Intelligence for Coronary Artery Disease Diagnosis: An Integrated Review.

Authors: Mehta, Heni Patel, Mili Vakharia, Manav et al.

Source: Archives of Computational Methods in Engineering; Dec2025, Vol. 32 Issue 8, p5295-5336, 42p

Associations between physical activity and CVD-related metabolomic and proteomic biomarkers.

Authors: Ekblom, Örjan Björkbacka, Harry Börjesson, Mats et al.

Source: PLoS ONE. 6/11/2025, Vol. 20 Issue 6, p1-22. 22p.

Resistance Exercise: A Potential Intervention for Managing Cardiovascular Health in Individuals with a History of Cancer.

Authors: Brooks, Alexander M. Lane, Abbi D. Kirkham, Amy A. et al.

Source: Sports Medicine - Open. 4/15/2026, Vol. 12 Issue 1, p1-13.

Associations of dual-energy computed tomography-derived visceral adipose tissue quality and high-risk coronary plaque in patients with metabolic syndrome.

Authors: Dang, Yuxue Ni, Weishi Zhen, Yanhua et al.

Source: Insights into Imaging. 4/20/2026, Vol. 17 Issue 1, p1-12. 12p.

Circulating RBP4 and FABP4 concentrations in patients with chronic schizophrenia are associated with increased epicardial adipose tissue volume and metabolic syndrome.

Authors: Lee, Thung-Lip Hsuan, Chin-Feng Lu, Nan-Han et al.

Source: European Archives of Psychiatry & Clinical Neuroscience. Apr2026, Vol. 276 Issue 3, p1199-1212. 14p.

Subjects: Epicardial adipose tissue, Fatty acid-binding proteins, Coronary artery disease, Schizophrenia, Retinol-binding proteins, Metabolic syndrome

Hyperphosphataemia, but not hypercalcaemia, predicts cardiovascular risk after kidney transplantation.

Authors: Agur, Timna Steinmetz, Tali Haran, Maya et al.

Source: Clinical Kidney Journal. Apr2026, Vol. 19 Issue 4, p1-10. 10p.

Deceased kidney donor cystatin C and subsequent recipient measured glomerular filtration rate at one year after transplantation.

Authors: Dielwart, Isabelle J. C. Kremer, Daan Knobbe, Tim J. et al.

Source: PLoS ONE. 3/10/2026, Vol. 21 Issue 3, p1-11. 11p.

Rewriting Diabetes Therapy: How Incretin Modulation is Transforming Cardiovascular and Renal Outcomes.

Authors: Miramontes-González, José Pablo Rodrigo-Alaíz, Álvaro Gabella-Martín, Miriam et al.

Source: Diabetes Therapy. Mar2026, Vol. 17 Issue 3, p317-330. 14p.

Índice de redondez corporal como predictor del síndrome metabólico pacientes con obesidad y diabetes mellitus de tipo 2.

Alternate Title: Body roundness index as a predictor of metabolic syndrome in patients with obesity and type 2 diabetes mellitus.

Authors: Luis, Daniel de López, Juan José Izaola, Olatz et al.

Source: Nutrición Hospitalaria. Mar/Apr2026, Vol. 43 Issue 2, p292-298. 7p.

Association between different metabolic obesity phenotypes and colorectal adenoma.

Authors: Lin, Li Ying, Yuhan Shu, Long et al.

Source: PLoS ONE. 2/23/2026, Vol. 21 Issue 2, p1-14. 14p.